
Auris Medical advances tinnitus drug therapy development with funds from CHF47.1mm Series C round
Executive Summary
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com